![Peter Olagunju](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Olagunju
Director de Operaciones en
TCR2 THERAPEUTICS INC.
.
Perfil
Peter Olagunju is currently the Chief Operating Officer at TCR2 Therapeutics, Inc. He previously worked as the Head-Quality at Dendreon Corp.
and ZymoGenetics, Inc. From 2015 to 2020, he served as the Vice President-Global Patient Operations at bluebird bio, Inc. and from 2020 to 2021, he was the Senior Vice President-Technical Operations at FerGene, Inc. Mr. Olagunju holds an MBA from the University of Washington and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Cargos activos de Peter Olagunju
| Empresas | Cargo | Inicio |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Director de Operaciones | 31/12/2022 |
Antiguos cargos conocidos de Peter Olagunju.
| Empresas | Cargo | Fin |
|---|---|---|
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Corporate Officer/Principal | 01/07/2021 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2020 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Corporate Officer/Principal | - |
| DENDREON CORPORATION | Corporate Officer/Principal | - |
Formación de Peter Olagunju.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
63
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Health Technology |
- Bolsa de valores
- Insiders
- Peter Olagunju
